Completed PHASE2 INTERVENTIONAL 1-arm NCT01661738

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002

Phase II Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine

Sponsor: Hualan Biological Engineering, Inc.

Interventions Group ACYW135 Meningococcal Polysaccharide Vaccine

Updated 5 times since 2017 Last updated: Aug 6, 2012 Started: May 31, 2006 Primary completion: May 31, 2006 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01661738, this PHASE2 trial focuses on Meningitis and remains completed. Sponsored by Hualan Biological Engineering, Inc., it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hualan Biological Engineering, Inc.

Data source: Hualan Biological Engineering, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.